tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
GTBP is currently covered by 1 analysts with an average price target of $7.06. This is a potential upside of $4.05 (134.55%) from yesterday's end of day stock price of $3.01.
GT Biopharma's activity chart (see below) currently has 0 price targets and 2 ratings on display. The stock rating distribution of GTBP is 100% HOLD.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 114 days.
Highest price target for GTBP is $32, Lowest price target is $17, average price target is $7.06.
Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 08-Aug-2023. First documented stock forecast 24-Jun-2021.
Currently out of the existing stock ratings of GTBP, 2 are a HOLD (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$5
$2.17 (76.68%)
$5
1 years 3 months 13 days ago
(08-Aug-2023)
5/5 (100%)
$-3.63 (-42.06%)
228
Buy
$26
$25.74 (9900.00%)
3 years 4 months 28 days ago
(24-Jun-2021)
0/1 (0%)
$11.72 (82.07%)
What is GTBP (GT Biopharma) average time for price targets to be met?
Which analyst has the current highest performing score on GTBP (GT Biopharma) with a proven track record?
Which analyst has the current lower performing score on GTBP (GT Biopharma) with a proven track record?
Which analyst has the most public recommendations on GTBP (GT Biopharma)?
Which analyst is the currently most bullish on GTBP (GT Biopharma)?
Which analyst is the currently most reserved on GTBP (GT Biopharma)?
